Councillor Irujo states that Navarra is entering a “strategic phase” to bring biotechnology and synthetic biology closer to the business sector, “both within and beyond the Chartered Community.”
A Navarrese delegation, headed by the Minister for Industry and Ecological and Digital Transition of Business, Mikel Irujo Amezaga, together with representatives of the public companies CEIN and Sodena and NASERTIC, the IRIS Innovation Pole of Navarre and Navarra Health Cluster, which are part of the Foral Community’s biotechnology ecosystem, as well as around twenty Navarrese companies and startups, have participated in BioSpain, the leading biotechnology event in Europe, which is being held in Bilbao until 1 October.
BioSpain is a leading international biotechnology trade fair that brings together biotechnology companies, investment entities, research centres, public administrations and agents from the innovation ecosystem with the aim of generating business, investment and international collaboration.
The Foral Community is taking part in the event for another year, with a shared space to showcase Navarre’s ecosystem around biotechnology and health sciences. During a meeting with the entire Navarrese ecosystem present at the event, Minister Irujo highlighted that “we are at a key moment for the development of biotechnology and synthetic biology in Navarre. We have entered a strategic phase with a dual objective: to bring biotechnology and synthetic biology closer to companies so that they can integrate them into their processes, and to highlight the capabilities of Navarre’s ecosystem, both within and outside the Foral Community”.
Navarre, an emerging hub for synthetic biology
Navarre is consolidating its position as an emerging synthetic biology hub thanks to the coordinated action of Sodena, CEIN and the IRIS Innovation Pole of Navarre, three actors that promote the development of this strategic field through investment, entrepreneurship, innovation and the generation of scientific and technological capabilities. Synthetic biology, which combines molecular biology, genetic engineering, automation, artificial intelligence and data analysis to develop new biosolutions, opens up high-impact opportunities in sectors such as healthcare, agri-food, sustainable energy and new materials.
Specifically, the IRIS Pole’s Synthetic Biology Laboratory, managed by the public company NASERTIC, has a unique technological innovation space and equipment in Navarre, open to companies, startups, research centres and technology centres, with the aim of developing a field that is set to play a key role in Navarre’s economic and industrial development in the coming years. In this regard, the Government of Navarre, through the Department of University, Innovation and Digital Transformation, will invest €2.5 million next year to create a “biofoundry”, an automated bioproduction facility that enables biological systems to be designed, built and tested at high speed in order to offer industrial solutions in the fields of biotechnology, healthcare and agri-food.
This drive is supported by an ecosystem that integrates universities, research centres, technology centres, cutting-edge infrastructures and more than 45 companies linked to advanced biotechnology. In this context, the IRIS Innovation Pole of Navarre provides specialised equipment and services for research and technological development, CEIN promotes the creation and scaling of new business initiatives, and Sodena helps mobilise investment and support the growth of innovative projects, facilitating the transfer of knowledge to the market and the development of new business opportunities.
Navarra Health Cluster emphasises that “BioSpain is a key event for Navarre’s business ecosystem, enabling us to connect our capabilities with opportunities within the national ecosystem. Navarre, as a hub for health and biosciences, has great potential to showcase year after year”.
Participating Navarrese companies
The around twenty Navarrese companies and startups present at the stand will be able to showcase their products and services and establish contact with potential customers, investors and partners.
They are Allbiotech, Amets Biotechnology, Betternostic, EAA Med Consulting, Embega Health Care, Eversens, First Assay, Genbioma, Guska, Innoup Farma, Insaight, Mimo Biosciences, Mirror Health, Nanogrow Biotech, Nucaps, Opportunity Health, Popcorn Therapeutics, Trimerbody Pharma and VLabs.
Several of these companies have taken part in the HEALTH ScaleUp programme for scaling emerging companies in the healthcare sector, run by the European Centre of Innovation and Business of Navarre (CEIN), or receive financial support from the Navarre Development Corporation (Sodena). In addition, nine of these startups will have the opportunity to give presentations to investors attending the trade fair.
Pamplona to host ATG Synbio Navarra Summit 2026
In the field of synthetic biology, Minister Irujo also highlighted the ATG Synbio Navarra Summit 2026, which will be held in Pamplona from 28 to 30 October and organised by ATG SynBio Spain in collaboration with the Government of Navarre, Sodena, CEIN and the IRIS Pole.
This international event will bring together leading figures from the scientific, business, investment and institutional sectors from around the world to analyse the challenges and opportunities of synthetic biology and the bioeconomy, promote knowledge generation and foster new global collaborations.
Source: navarra.es